I bought this a couple of weeks ago after doing my DD. About 81% of the O/S shares are owned by institutions and insiders, it has enough cash to take it through 2012, and the pipeline is very strong. By my count, it has 18 Phase 1-3 trials ongoing, and one drug at commercial stage. I can not understand why I am not seeing more buzz about this one.
News 
Market Data 
Discover 
